卫星化学：10月24日召开董事会会议

Group 1 - The core point of the article is that Satellite Chemical (SZ 002648) held its 12th meeting of the 5th Board of Directors on October 24, 2025, to discuss the revision of the "Audit Committee Work Rules" and other documents [1] - For the first half of 2025, Satellite Chemical's revenue composition was 88.35% from the chemical production industry and 11.65% from other businesses [1] - As of the time of reporting, Satellite Chemical's market capitalization was 61.4 billion yuan [1] Group 2 - The article mentions that the Chinese innovative drug sector has sold overseas authorizations worth 80 billion USD this year, highlighting the hot secondary market in biomedicine [1] - A dialogue with Lu Gang, a partner at Chuangdong Investment, indicates that while the secondary market is thriving, the primary market is facing challenges in fundraising [1]